Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Antivirals). Showing records 1 – 30 of 92 total matches.

[1] [2] [3] [4]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


Oregon State University

1. Lupfer, Christopher. Targeted development of antivirals against influenza A and respiratory syncytial virus.

Degree: PhD, Genetics, 2009, Oregon State University

 Influenza A and Respiratory Syncytial Virus (RSV) are both enveloped, negative strand RNA viruses which infect the respiratory mucosa of animals and humans. Despite decades… (more)

Subjects/Keywords: Antivirals; Influenza A virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lupfer, C. (2009). Targeted development of antivirals against influenza A and respiratory syncytial virus. (Doctoral Dissertation). Oregon State University. Retrieved from http://hdl.handle.net/1957/11948

Chicago Manual of Style (16th Edition):

Lupfer, Christopher. “Targeted development of antivirals against influenza A and respiratory syncytial virus.” 2009. Doctoral Dissertation, Oregon State University. Accessed April 17, 2021. http://hdl.handle.net/1957/11948.

MLA Handbook (7th Edition):

Lupfer, Christopher. “Targeted development of antivirals against influenza A and respiratory syncytial virus.” 2009. Web. 17 Apr 2021.

Vancouver:

Lupfer C. Targeted development of antivirals against influenza A and respiratory syncytial virus. [Internet] [Doctoral dissertation]. Oregon State University; 2009. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1957/11948.

Council of Science Editors:

Lupfer C. Targeted development of antivirals against influenza A and respiratory syncytial virus. [Doctoral Dissertation]. Oregon State University; 2009. Available from: http://hdl.handle.net/1957/11948


University of New South Wales

2. Enosi Tuipulotu, Daniel. Norovirus antiviral discovery: host-modulators and direct-acting antivirals.

Degree: Biotechnology & Biomolecular Sciences, 2018, University of New South Wales

 Human norovirus is a leading cause of acute gastroenteritis (AGE) worldwide and is estimated to be responsible for over 200,000 deaths each year. Norovirus infections… (more)

Subjects/Keywords: Nucleoside analogue (NA); Norovirus; Antivirals

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Enosi Tuipulotu, D. (2018). Norovirus antiviral discovery: host-modulators and direct-acting antivirals. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/62681 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:58917/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Enosi Tuipulotu, Daniel. “Norovirus antiviral discovery: host-modulators and direct-acting antivirals.” 2018. Doctoral Dissertation, University of New South Wales. Accessed April 17, 2021. http://handle.unsw.edu.au/1959.4/62681 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:58917/SOURCE02?view=true.

MLA Handbook (7th Edition):

Enosi Tuipulotu, Daniel. “Norovirus antiviral discovery: host-modulators and direct-acting antivirals.” 2018. Web. 17 Apr 2021.

Vancouver:

Enosi Tuipulotu D. Norovirus antiviral discovery: host-modulators and direct-acting antivirals. [Internet] [Doctoral dissertation]. University of New South Wales; 2018. [cited 2021 Apr 17]. Available from: http://handle.unsw.edu.au/1959.4/62681 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:58917/SOURCE02?view=true.

Council of Science Editors:

Enosi Tuipulotu D. Norovirus antiviral discovery: host-modulators and direct-acting antivirals. [Doctoral Dissertation]. University of New South Wales; 2018. Available from: http://handle.unsw.edu.au/1959.4/62681 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:58917/SOURCE02?view=true


University of New South Wales

3. Netzler, Natalie. Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae.

Degree: Biotechnology & Biomolecular Sciences, 2019, University of New South Wales

 Human pathogens from the Caliciviridae and Hepeviridae families impose a significant health and economic burden on our global society. Despite the substantial toll caused by… (more)

Subjects/Keywords: Norovirus; Antivirals; Broad-spectrum antivirals; Hepatitis E virus; Caliciviridae; Hepeviridae

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Netzler, N. (2019). Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/62685 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:59105/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Netzler, Natalie. “Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae.” 2019. Doctoral Dissertation, University of New South Wales. Accessed April 17, 2021. http://handle.unsw.edu.au/1959.4/62685 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:59105/SOURCE02?view=true.

MLA Handbook (7th Edition):

Netzler, Natalie. “Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae.” 2019. Web. 17 Apr 2021.

Vancouver:

Netzler N. Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae. [Internet] [Doctoral dissertation]. University of New South Wales; 2019. [cited 2021 Apr 17]. Available from: http://handle.unsw.edu.au/1959.4/62685 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:59105/SOURCE02?view=true.

Council of Science Editors:

Netzler N. Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae. [Doctoral Dissertation]. University of New South Wales; 2019. Available from: http://handle.unsw.edu.au/1959.4/62685 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:59105/SOURCE02?view=true


Virginia Commonwealth University

4. Bhave, Sukhada. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.

Degree: MS, Microbiology & Immunology, 2012, Virginia Commonwealth University

 Cytomegalovirus (CMV) infections remain a significant problem in congenitally infected infants and immunocompromised individuals. Modest antiviral activities of currently approved drugs coupled with dose-limiting toxicities… (more)

Subjects/Keywords: cytomegalovirus; antivirals; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bhave, S. (2012). INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. (Thesis). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/CNVY-TJ48 ; https://scholarscompass.vcu.edu/etd/2838

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bhave, Sukhada. “INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.” 2012. Thesis, Virginia Commonwealth University. Accessed April 17, 2021. https://doi.org/10.25772/CNVY-TJ48 ; https://scholarscompass.vcu.edu/etd/2838.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bhave, Sukhada. “INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.” 2012. Web. 17 Apr 2021.

Vancouver:

Bhave S. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. [Internet] [Thesis]. Virginia Commonwealth University; 2012. [cited 2021 Apr 17]. Available from: https://doi.org/10.25772/CNVY-TJ48 ; https://scholarscompass.vcu.edu/etd/2838.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bhave S. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. [Thesis]. Virginia Commonwealth University; 2012. Available from: https://doi.org/10.25772/CNVY-TJ48 ; https://scholarscompass.vcu.edu/etd/2838

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universitat Autònoma de Barcelona

5. Chen, Qian. Caracterización molecular del perfil de resistencias del virus de la hepatitis C después del fallo terapéutico a antivirales de acción directa mediante secuenciación masiva.

Degree: Departament de Medicina, 2018, Universitat Autònoma de Barcelona

 Chronic hepatitis C infection is considered as a major public health issue worldwide due to its linkage to the development of advanced liver diseases and… (more)

Subjects/Keywords: Hepatitis; Resistències; Resistencias; Resistance; Antivirals; Antivirales; Antivirals; Ciències de la Salut; 578

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, Q. (2018). Caracterización molecular del perfil de resistencias del virus de la hepatitis C después del fallo terapéutico a antivirales de acción directa mediante secuenciación masiva. (Thesis). Universitat Autònoma de Barcelona. Retrieved from http://hdl.handle.net/10803/666656

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chen, Qian. “Caracterización molecular del perfil de resistencias del virus de la hepatitis C después del fallo terapéutico a antivirales de acción directa mediante secuenciación masiva.” 2018. Thesis, Universitat Autònoma de Barcelona. Accessed April 17, 2021. http://hdl.handle.net/10803/666656.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chen, Qian. “Caracterización molecular del perfil de resistencias del virus de la hepatitis C después del fallo terapéutico a antivirales de acción directa mediante secuenciación masiva.” 2018. Web. 17 Apr 2021.

Vancouver:

Chen Q. Caracterización molecular del perfil de resistencias del virus de la hepatitis C después del fallo terapéutico a antivirales de acción directa mediante secuenciación masiva. [Internet] [Thesis]. Universitat Autònoma de Barcelona; 2018. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10803/666656.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chen Q. Caracterización molecular del perfil de resistencias del virus de la hepatitis C después del fallo terapéutico a antivirales de acción directa mediante secuenciación masiva. [Thesis]. Universitat Autònoma de Barcelona; 2018. Available from: http://hdl.handle.net/10803/666656

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

6. Hadpech, Sudarat. Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation.

Degree: Docteur es, Biologie, 2017, Lyon; Mahāwitthayālai Chīang Mai

Au cours de notre programme de thèse, nous avons isolé et caractérisé des molécules protéiques à activité antivirale intracellulaire dirigée contre le VIH-1. Ces protéines,… (more)

Subjects/Keywords: Antivirals; VIH-1; Protéines à motifs répétés; AlphaRep; Antivirals; HIV-1; Repeat proteins; AlphaRep; 572

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hadpech, S. (2017). Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation. (Doctoral Dissertation). Lyon; Mahāwitthayālai Chīang Mai. Retrieved from http://www.theses.fr/2017LYSE1139

Chicago Manual of Style (16th Edition):

Hadpech, Sudarat. “Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation.” 2017. Doctoral Dissertation, Lyon; Mahāwitthayālai Chīang Mai. Accessed April 17, 2021. http://www.theses.fr/2017LYSE1139.

MLA Handbook (7th Edition):

Hadpech, Sudarat. “Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation.” 2017. Web. 17 Apr 2021.

Vancouver:

Hadpech S. Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation. [Internet] [Doctoral dissertation]. Lyon; Mahāwitthayālai Chīang Mai; 2017. [cited 2021 Apr 17]. Available from: http://www.theses.fr/2017LYSE1139.

Council of Science Editors:

Hadpech S. Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation. [Doctoral Dissertation]. Lyon; Mahāwitthayālai Chīang Mai; 2017. Available from: http://www.theses.fr/2017LYSE1139


Universitat Pompeu Fabra

7. Fleta Soriano, Eric, 1983-. Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs.

Degree: Departament de Ciències Experimentals i de la Salut, 2015, Universitat Pompeu Fabra

 Cientos de factores del huésped relacionados con infecciones virales por VIH, hepatitis C, dengue o virus del Nilo occidental han sido identificados. Como muchos de… (more)

Subjects/Keywords: Broad-spectrum antivirals; Host-actings antivirals; HIV; Soraphen A; Ratjadone A; VIH; Antiiviral amplio aspectro; Antiviral contra hospedador; 578

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fleta Soriano, Eric, 1. (2015). Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs. (Thesis). Universitat Pompeu Fabra. Retrieved from http://hdl.handle.net/10803/402212

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fleta Soriano, Eric, 1983-. “Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs.” 2015. Thesis, Universitat Pompeu Fabra. Accessed April 17, 2021. http://hdl.handle.net/10803/402212.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fleta Soriano, Eric, 1983-. “Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs.” 2015. Web. 17 Apr 2021.

Vancouver:

Fleta Soriano, Eric 1. Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs. [Internet] [Thesis]. Universitat Pompeu Fabra; 2015. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10803/402212.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fleta Soriano, Eric 1. Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs. [Thesis]. Universitat Pompeu Fabra; 2015. Available from: http://hdl.handle.net/10803/402212

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Loyola University Chicago

8. Banach, Bridget. A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism.

Degree: PhD, Microbiology and Immunology, 2012, Loyola University Chicago

  Acute respiratory tract infections in humans are responsible for significant morbidity and mortality especially in children, elderly, and the immunocompromised. Virus infection is the… (more)

Subjects/Keywords: Antivirals; HCoV-NL63; human airway epithelium; immunofluorescence; PLP2; TEM; Virology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Banach, B. (2012). A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism. (Doctoral Dissertation). Loyola University Chicago. Retrieved from https://ecommons.luc.edu/luc_diss_restrict/12

Chicago Manual of Style (16th Edition):

Banach, Bridget. “A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism.” 2012. Doctoral Dissertation, Loyola University Chicago. Accessed April 17, 2021. https://ecommons.luc.edu/luc_diss_restrict/12.

MLA Handbook (7th Edition):

Banach, Bridget. “A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism.” 2012. Web. 17 Apr 2021.

Vancouver:

Banach B. A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism. [Internet] [Doctoral dissertation]. Loyola University Chicago; 2012. [cited 2021 Apr 17]. Available from: https://ecommons.luc.edu/luc_diss_restrict/12.

Council of Science Editors:

Banach B. A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism. [Doctoral Dissertation]. Loyola University Chicago; 2012. Available from: https://ecommons.luc.edu/luc_diss_restrict/12

9. Jesteadt, Eric Matthew Neff. USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS.

Degree: 2014, Johns Hopkins University

 Influenza is a global public health burden, producing seasonal epidemics with 3-5 million severe cases and 250,000 to 500,000 deaths each year. In addition to… (more)

Subjects/Keywords: Influenza; RNAi; antivirals; therapeutics

antivirals that can be used to control an infection. These are the neuraminidase inhibitors and the… …second class of antivirals, the adamantanes, includes amantadine and rimantadine (32)… …antivirals useless. RNA interference and the basics of RNAi therapeutics An attractive alternative… …to antivirals is the development of treatments based on the mechanism of RNA interference… …vectors expressing shRNAs (50). RNA interference-based antivirals against Respiratory… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jesteadt, E. M. N. (2014). USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37266

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jesteadt, Eric Matthew Neff. “USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS.” 2014. Thesis, Johns Hopkins University. Accessed April 17, 2021. http://jhir.library.jhu.edu/handle/1774.2/37266.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jesteadt, Eric Matthew Neff. “USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS.” 2014. Web. 17 Apr 2021.

Vancouver:

Jesteadt EMN. USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2021 Apr 17]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37266.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Jesteadt EMN. USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/37266

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. Perrier, Anabelle. Etude du trafic intracellulaire de la protéine M du coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) : Intracellular trafficking of the M protein of Middle East respiratory syndrome coronavirus (MERS-CoV).

Degree: Docteur es, Biochimie, biologie cellulaire et moléculaire, physiologie et nutrition, 2019, Université Lille II – Droit et Santé

Les coronavirus sont une famille de virus émergents, comme l’ont montré les émergences récentes des coronavirus SARS-CoV (Severe acute respiratory syndrome coronavirus) et MERS-CoV (Middle-East… (more)

Subjects/Keywords: Antiviraux; Trafic intracellulaire; Protéine M; Intracellular trafficking; Antivirals; M protein

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Perrier, A. (2019). Etude du trafic intracellulaire de la protéine M du coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) : Intracellular trafficking of the M protein of Middle East respiratory syndrome coronavirus (MERS-CoV). (Doctoral Dissertation). Université Lille II – Droit et Santé. Retrieved from http://www.theses.fr/2019LIL2S018

Chicago Manual of Style (16th Edition):

Perrier, Anabelle. “Etude du trafic intracellulaire de la protéine M du coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) : Intracellular trafficking of the M protein of Middle East respiratory syndrome coronavirus (MERS-CoV).” 2019. Doctoral Dissertation, Université Lille II – Droit et Santé. Accessed April 17, 2021. http://www.theses.fr/2019LIL2S018.

MLA Handbook (7th Edition):

Perrier, Anabelle. “Etude du trafic intracellulaire de la protéine M du coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) : Intracellular trafficking of the M protein of Middle East respiratory syndrome coronavirus (MERS-CoV).” 2019. Web. 17 Apr 2021.

Vancouver:

Perrier A. Etude du trafic intracellulaire de la protéine M du coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) : Intracellular trafficking of the M protein of Middle East respiratory syndrome coronavirus (MERS-CoV). [Internet] [Doctoral dissertation]. Université Lille II – Droit et Santé 2019. [cited 2021 Apr 17]. Available from: http://www.theses.fr/2019LIL2S018.

Council of Science Editors:

Perrier A. Etude du trafic intracellulaire de la protéine M du coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) : Intracellular trafficking of the M protein of Middle East respiratory syndrome coronavirus (MERS-CoV). [Doctoral Dissertation]. Université Lille II – Droit et Santé 2019. Available from: http://www.theses.fr/2019LIL2S018


University of Manitoba

11. Cook, Bradley William Michael. Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus.

Degree: Microbiology, 2015, University of Manitoba

 Kyasanur Forest disease virus (KFDV) of the Flaviviridae virus family has caused seasonal infections and periodic outbreaks in Karnataka, India. First identified in 1957, KFDV… (more)

Subjects/Keywords: Flavivirus; Tick-borne flavivirus; Interferon; Molecular biology; Antivirals; Hemorrhagic fever virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cook, B. W. M. (2015). Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus. (Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/30913

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Cook, Bradley William Michael. “Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus.” 2015. Thesis, University of Manitoba. Accessed April 17, 2021. http://hdl.handle.net/1993/30913.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Cook, Bradley William Michael. “Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus.” 2015. Web. 17 Apr 2021.

Vancouver:

Cook BWM. Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus. [Internet] [Thesis]. University of Manitoba; 2015. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1993/30913.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Cook BWM. Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus. [Thesis]. University of Manitoba; 2015. Available from: http://hdl.handle.net/1993/30913

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

12. Bekking, Christian. Assessment of Bioaerosol Samplers for the Detection and Quantification of Influenza Virus and Compounds that Potentially Influence Influenza Virus Replication.

Degree: 2018, University of Toronto

Bioaerosol samplers are used to detect and characterize influenza virus bioaerosols but current guidelines for sampler selection are lacking. We examined four bioaerosol samplers using… (more)

Subjects/Keywords: Antivirals; Bioaerosols; Bioaerosol samplers; Cardiac glycosides; Emission; Influenza; 0720

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bekking, C. (2018). Assessment of Bioaerosol Samplers for the Detection and Quantification of Influenza Virus and Compounds that Potentially Influence Influenza Virus Replication. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/102815

Chicago Manual of Style (16th Edition):

Bekking, Christian. “Assessment of Bioaerosol Samplers for the Detection and Quantification of Influenza Virus and Compounds that Potentially Influence Influenza Virus Replication.” 2018. Masters Thesis, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/102815.

MLA Handbook (7th Edition):

Bekking, Christian. “Assessment of Bioaerosol Samplers for the Detection and Quantification of Influenza Virus and Compounds that Potentially Influence Influenza Virus Replication.” 2018. Web. 17 Apr 2021.

Vancouver:

Bekking C. Assessment of Bioaerosol Samplers for the Detection and Quantification of Influenza Virus and Compounds that Potentially Influence Influenza Virus Replication. [Internet] [Masters thesis]. University of Toronto; 2018. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/102815.

Council of Science Editors:

Bekking C. Assessment of Bioaerosol Samplers for the Detection and Quantification of Influenza Virus and Compounds that Potentially Influence Influenza Virus Replication. [Masters Thesis]. University of Toronto; 2018. Available from: http://hdl.handle.net/1807/102815


University of Georgia

13. Carter, Leah D.b. Who gets the cure?.

Degree: 2017, University of Georgia

 Using the Hepatitis C Virus (HCV) as a focal point and newly approved Direct-Acting Antivirals as the impetus for change, this thesis explores the course… (more)

Subjects/Keywords: Regulatory Affairs; Medicaid; Hepatitis C; Direct-Acting Antivirals; Ryan White

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Carter, L. D. b. (2017). Who gets the cure?. (Thesis). University of Georgia. Retrieved from http://hdl.handle.net/10724/36636

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Carter, Leah D b. “Who gets the cure?.” 2017. Thesis, University of Georgia. Accessed April 17, 2021. http://hdl.handle.net/10724/36636.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Carter, Leah D b. “Who gets the cure?.” 2017. Web. 17 Apr 2021.

Vancouver:

Carter LDb. Who gets the cure?. [Internet] [Thesis]. University of Georgia; 2017. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10724/36636.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Carter LDb. Who gets the cure?. [Thesis]. University of Georgia; 2017. Available from: http://hdl.handle.net/10724/36636

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Sydney

14. Swaminathan, Kavya. Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry .

Degree: 2013, University of Sydney

 A novel matrix assisted laser desorption ionization (MALDI) mass spectrometry based approach to study the binding of inhibitors to the influenza virus neuraminidase is described.… (more)

Subjects/Keywords: Influenza; Antivirals; MassTrees; Anthocyanin; Drug resistance; Mass spectrometry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Swaminathan, K. (2013). Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/10220

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Swaminathan, Kavya. “Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry .” 2013. Thesis, University of Sydney. Accessed April 17, 2021. http://hdl.handle.net/2123/10220.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Swaminathan, Kavya. “Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry .” 2013. Web. 17 Apr 2021.

Vancouver:

Swaminathan K. Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry . [Internet] [Thesis]. University of Sydney; 2013. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/2123/10220.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Swaminathan K. Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry . [Thesis]. University of Sydney; 2013. Available from: http://hdl.handle.net/2123/10220

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of New South Wales

15. Eltahla, Auda Abdelsalam. Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design.

Degree: Biotechnology & Biomolecular Sciences, 2014, University of New South Wales

 The hepatitis C virus (HCV) and norovirus (NoV) are significant human pathogens posing a substantial health and economic burden in both developing and developed countries.… (more)

Subjects/Keywords: RNA-dependent RNA polymerase; Hepatitis C virus; Norovirus; Antivirals

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Eltahla, A. A. (2014). Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/53565 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:12262/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Eltahla, Auda Abdelsalam. “Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design.” 2014. Doctoral Dissertation, University of New South Wales. Accessed April 17, 2021. http://handle.unsw.edu.au/1959.4/53565 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:12262/SOURCE02?view=true.

MLA Handbook (7th Edition):

Eltahla, Auda Abdelsalam. “Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design.” 2014. Web. 17 Apr 2021.

Vancouver:

Eltahla AA. Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design. [Internet] [Doctoral dissertation]. University of New South Wales; 2014. [cited 2021 Apr 17]. Available from: http://handle.unsw.edu.au/1959.4/53565 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:12262/SOURCE02?view=true.

Council of Science Editors:

Eltahla AA. Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design. [Doctoral Dissertation]. University of New South Wales; 2014. Available from: http://handle.unsw.edu.au/1959.4/53565 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:12262/SOURCE02?view=true


Queen Mary, University of London

16. Wing, Peter Alexander Cornelius. Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals.

Degree: PhD, 2018, Queen Mary, University of London

 Sofosbuvir is a uridine based nucleotide inhibitor of the hepatitis C viral (HCV) polymerase that is the backbone of many treatment regimens. In combination with… (more)

Subjects/Keywords: 616.3; HEPATITIS C VIRUS; Antivirals; sofosbuvir; Genotype 3 HCV

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wing, P. A. C. (2018). Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/44044 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766210

Chicago Manual of Style (16th Edition):

Wing, Peter Alexander Cornelius. “Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals.” 2018. Doctoral Dissertation, Queen Mary, University of London. Accessed April 17, 2021. http://qmro.qmul.ac.uk/xmlui/handle/123456789/44044 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766210.

MLA Handbook (7th Edition):

Wing, Peter Alexander Cornelius. “Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals.” 2018. Web. 17 Apr 2021.

Vancouver:

Wing PAC. Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2018. [cited 2021 Apr 17]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/44044 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766210.

Council of Science Editors:

Wing PAC. Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals. [Doctoral Dissertation]. Queen Mary, University of London; 2018. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/44044 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766210

17. O'Rourke, Aubrie. Bioprospecting of Red Sea Sponges for Novel Antiviral Pharmacophores.

Degree: Biological and Environmental Sciences and Engineering (BESE) Division, 2015, King Abdullah University of Science and Technology

 Natural products offer many possibilities for the treatment of disease. More than 70% of the Earth’s surface is ocean, and recent exploration and access has… (more)

Subjects/Keywords: Antivirals; Red Sea; Sponges; West Nile Virus; HIV-I; Natural products

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

O'Rourke, A. (2015). Bioprospecting of Red Sea Sponges for Novel Antiviral Pharmacophores. (Thesis). King Abdullah University of Science and Technology. Retrieved from http://hdl.handle.net/10754/552842

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

O'Rourke, Aubrie. “Bioprospecting of Red Sea Sponges for Novel Antiviral Pharmacophores.” 2015. Thesis, King Abdullah University of Science and Technology. Accessed April 17, 2021. http://hdl.handle.net/10754/552842.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

O'Rourke, Aubrie. “Bioprospecting of Red Sea Sponges for Novel Antiviral Pharmacophores.” 2015. Web. 17 Apr 2021.

Vancouver:

O'Rourke A. Bioprospecting of Red Sea Sponges for Novel Antiviral Pharmacophores. [Internet] [Thesis]. King Abdullah University of Science and Technology; 2015. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10754/552842.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

O'Rourke A. Bioprospecting of Red Sea Sponges for Novel Antiviral Pharmacophores. [Thesis]. King Abdullah University of Science and Technology; 2015. Available from: http://hdl.handle.net/10754/552842

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. Batista, Mariana Nogueira. Avaliação de peptídeos sintéticos na inibição direcionada do vírus da hepatite C.

Degree: 2018, Universidade Estadual Paulista (UNESP)

Submitted by Mariana Nogueira Batista ([email protected]) on 2018-08-11T13:03:25Z No. of bitstreams: 1 Tese Doutorado_Mariana_final.pdf: 7344224 bytes, checksum: 55aafb62a666837e6ce68354b806d8af (MD5)

Rejected by Elza Mitiko Sato null… (more)

Subjects/Keywords: HCV; Pró-fármaco; Antivirais; Hecate; GA-Hecate; Lipid droplets; Prodrug; Antivirals

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Batista, M. N. (2018). Avaliação de peptídeos sintéticos na inibição direcionada do vírus da hepatite C. (Doctoral Dissertation). Universidade Estadual Paulista (UNESP). Retrieved from http://hdl.handle.net/11449/154951

Chicago Manual of Style (16th Edition):

Batista, Mariana Nogueira. “Avaliação de peptídeos sintéticos na inibição direcionada do vírus da hepatite C.” 2018. Doctoral Dissertation, Universidade Estadual Paulista (UNESP). Accessed April 17, 2021. http://hdl.handle.net/11449/154951.

MLA Handbook (7th Edition):

Batista, Mariana Nogueira. “Avaliação de peptídeos sintéticos na inibição direcionada do vírus da hepatite C.” 2018. Web. 17 Apr 2021.

Vancouver:

Batista MN. Avaliação de peptídeos sintéticos na inibição direcionada do vírus da hepatite C. [Internet] [Doctoral dissertation]. Universidade Estadual Paulista (UNESP); 2018. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/11449/154951.

Council of Science Editors:

Batista MN. Avaliação de peptídeos sintéticos na inibição direcionada do vírus da hepatite C. [Doctoral Dissertation]. Universidade Estadual Paulista (UNESP); 2018. Available from: http://hdl.handle.net/11449/154951

19. Sindac, Janice A. Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus.

Degree: PhD, Medicinal Chemistry, 2014, University of Michigan

 Arborviruses such as western equine encephalitis virus (WEEV) are capable of causing a wide range of diseases in humans. The CDC and NIAID consider WEEV… (more)

Subjects/Keywords: alphavirus; antivirals; Biological Chemistry; Science

…emphasizes the significance of this work, as there is a critical need to develop potent antivirals… …the CNS emphasizes the need for antivirals to prevent viral replication and neuroprotective… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sindac, J. A. (2014). Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/110326

Chicago Manual of Style (16th Edition):

Sindac, Janice A. “Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus.” 2014. Doctoral Dissertation, University of Michigan. Accessed April 17, 2021. http://hdl.handle.net/2027.42/110326.

MLA Handbook (7th Edition):

Sindac, Janice A. “Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus.” 2014. Web. 17 Apr 2021.

Vancouver:

Sindac JA. Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus. [Internet] [Doctoral dissertation]. University of Michigan; 2014. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/2027.42/110326.

Council of Science Editors:

Sindac JA. Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus. [Doctoral Dissertation]. University of Michigan; 2014. Available from: http://hdl.handle.net/2027.42/110326

20. Aillot, Ludovic. Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV.

Degree: Docteur es, Infectiologie, 2018, Lyon

 Le virus de l'hépatite B (HBV) infecte chroniquement près de 240 millions d'individus dans le monde. L'infection chronique par HBV est un souci de santé… (more)

Subjects/Keywords: HBV; Toll-like Récepteurs; Antiviraux; Immunité innée; HBV; Toll-like Receptors; Antivirals; Innate immunity; 572

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aillot, L. (2018). Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2018LYSE1139

Chicago Manual of Style (16th Edition):

Aillot, Ludovic. “Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV.” 2018. Doctoral Dissertation, Lyon. Accessed April 17, 2021. http://www.theses.fr/2018LYSE1139.

MLA Handbook (7th Edition):

Aillot, Ludovic. “Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV.” 2018. Web. 17 Apr 2021.

Vancouver:

Aillot L. Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV. [Internet] [Doctoral dissertation]. Lyon; 2018. [cited 2021 Apr 17]. Available from: http://www.theses.fr/2018LYSE1139.

Council of Science Editors:

Aillot L. Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV. [Doctoral Dissertation]. Lyon; 2018. Available from: http://www.theses.fr/2018LYSE1139

21. Foca, Adrien. Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B.

Degree: Docteur es, Virologie et cancérologie, 2018, Lyon

 Dans les régions de fortes endémicités, 70-80% des carcinomes hépatocellulaires sont induits par le VHB. Bien qu’un vaccin prophylactique très efficace existe, il n’est d’aucune… (more)

Subjects/Keywords: PLK1; ARN interférents; Hépatite B; Carcinome hépatocellulaire; Antiviraux; PLK1; SiRNA; HBV; HCC; Antivirals HTA; 570

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Foca, A. (2018). Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2018LYSE1310

Chicago Manual of Style (16th Edition):

Foca, Adrien. “Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B.” 2018. Doctoral Dissertation, Lyon. Accessed April 17, 2021. http://www.theses.fr/2018LYSE1310.

MLA Handbook (7th Edition):

Foca, Adrien. “Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B.” 2018. Web. 17 Apr 2021.

Vancouver:

Foca A. Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B. [Internet] [Doctoral dissertation]. Lyon; 2018. [cited 2021 Apr 17]. Available from: http://www.theses.fr/2018LYSE1310.

Council of Science Editors:

Foca A. Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B. [Doctoral Dissertation]. Lyon; 2018. Available from: http://www.theses.fr/2018LYSE1310

22. Richard, Mathilde. Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin.

Degree: Docteur es, Virologie, 2010, Université Claude Bernard – Lyon I

Chaque année, les épidémies de grippe, dont les principaux agents étiologiques sont les virus influenza de type A, ont un impact considérable sur la population… (more)

Subjects/Keywords: Influenza; Neuraminidase; Antiviraux; Résistance; Balance fonctionnelle; Influenza; Neuraminidase; Antivirals; Resistance; Functionnal balance; 616.203

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Richard, M. (2010). Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin. (Doctoral Dissertation). Université Claude Bernard – Lyon I. Retrieved from http://www.theses.fr/2010LYO10323

Chicago Manual of Style (16th Edition):

Richard, Mathilde. “Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin.” 2010. Doctoral Dissertation, Université Claude Bernard – Lyon I. Accessed April 17, 2021. http://www.theses.fr/2010LYO10323.

MLA Handbook (7th Edition):

Richard, Mathilde. “Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin.” 2010. Web. 17 Apr 2021.

Vancouver:

Richard M. Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin. [Internet] [Doctoral dissertation]. Université Claude Bernard – Lyon I; 2010. [cited 2021 Apr 17]. Available from: http://www.theses.fr/2010LYO10323.

Council of Science Editors:

Richard M. Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin. [Doctoral Dissertation]. Université Claude Bernard – Lyon I; 2010. Available from: http://www.theses.fr/2010LYO10323


Boston University

23. Buczek, Magdalena Marta. Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital.

Degree: MS, Medical Sciences, 2017, Boston University

 INTRODUCTION: Mortality associated with hepatitis C virus (HCV) infection is increasing, yet only a small percentage of HCV-infected individuals are aware of their infections, complete… (more)

Subjects/Keywords: Medicine; Direct-acting antivirals; Hepatitis C virus; Multidisciplinary team; Pharmacy; Primary care; Social work

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Buczek, M. M. (2017). Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/23754

Chicago Manual of Style (16th Edition):

Buczek, Magdalena Marta. “Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital.” 2017. Masters Thesis, Boston University. Accessed April 17, 2021. http://hdl.handle.net/2144/23754.

MLA Handbook (7th Edition):

Buczek, Magdalena Marta. “Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital.” 2017. Web. 17 Apr 2021.

Vancouver:

Buczek MM. Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital. [Internet] [Masters thesis]. Boston University; 2017. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/2144/23754.

Council of Science Editors:

Buczek MM. Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital. [Masters Thesis]. Boston University; 2017. Available from: http://hdl.handle.net/2144/23754


University of California – San Francisco

24. Asher, Alice Kathleen. Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals.

Degree: Nursing, 2015, University of California – San Francisco

 Hepatitis C virus (HCV) infection affects millions of Americans at a high public health cost. Despite the availability of a curative treatment, a significant proportion… (more)

Subjects/Keywords: Nursing; clinicians; direct-acting antivirals; Hepatitis C treatment; People who inject drugs

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Asher, A. K. (2015). Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals. (Thesis). University of California – San Francisco. Retrieved from http://www.escholarship.org/uc/item/1cz9c2f6

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Asher, Alice Kathleen. “Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals.” 2015. Thesis, University of California – San Francisco. Accessed April 17, 2021. http://www.escholarship.org/uc/item/1cz9c2f6.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Asher, Alice Kathleen. “Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals.” 2015. Web. 17 Apr 2021.

Vancouver:

Asher AK. Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals. [Internet] [Thesis]. University of California – San Francisco; 2015. [cited 2021 Apr 17]. Available from: http://www.escholarship.org/uc/item/1cz9c2f6.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Asher AK. Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals. [Thesis]. University of California – San Francisco; 2015. Available from: http://www.escholarship.org/uc/item/1cz9c2f6

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

25. Casey, Julia. Restoration of Hepatitis C Virus-specific Immune Responses following Direct Acting Antivirals Administered During Acute Hepatitis C Virus Infection.

Degree: 2020, University of Toronto

Worldwide, 71 million people are chronically infected with Hepatitis C Virus (HCV). Chronic HCV infection leads to potentially fatal outcomes including liver cirrhosis and hepatocellular… (more)

Subjects/Keywords: Direct Acting Antivirals; Hepatitis C Virus; Immune Exhaustion; Immune Restoration; Protective Immunity; Reinfection; 0982

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Casey, J. (2020). Restoration of Hepatitis C Virus-specific Immune Responses following Direct Acting Antivirals Administered During Acute Hepatitis C Virus Infection. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/103341

Chicago Manual of Style (16th Edition):

Casey, Julia. “Restoration of Hepatitis C Virus-specific Immune Responses following Direct Acting Antivirals Administered During Acute Hepatitis C Virus Infection.” 2020. Masters Thesis, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/103341.

MLA Handbook (7th Edition):

Casey, Julia. “Restoration of Hepatitis C Virus-specific Immune Responses following Direct Acting Antivirals Administered During Acute Hepatitis C Virus Infection.” 2020. Web. 17 Apr 2021.

Vancouver:

Casey J. Restoration of Hepatitis C Virus-specific Immune Responses following Direct Acting Antivirals Administered During Acute Hepatitis C Virus Infection. [Internet] [Masters thesis]. University of Toronto; 2020. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/103341.

Council of Science Editors:

Casey J. Restoration of Hepatitis C Virus-specific Immune Responses following Direct Acting Antivirals Administered During Acute Hepatitis C Virus Infection. [Masters Thesis]. University of Toronto; 2020. Available from: http://hdl.handle.net/1807/103341


University of Edinburgh

26. Imhof, Ingrid. Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6.

Degree: PhD, 2010, University of Edinburgh

 The development of specific antiviral drugs directly targeting the hepatitis C virus (HCV) is clinically important, as the current standard interferon/ribavirin combination treatment is only… (more)

Subjects/Keywords: 615; HCV; hepatitis C virus; antivirals

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Imhof, I. (2010). Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6. (Doctoral Dissertation). University of Edinburgh. Retrieved from http://hdl.handle.net/1842/6207

Chicago Manual of Style (16th Edition):

Imhof, Ingrid. “Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6.” 2010. Doctoral Dissertation, University of Edinburgh. Accessed April 17, 2021. http://hdl.handle.net/1842/6207.

MLA Handbook (7th Edition):

Imhof, Ingrid. “Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6.” 2010. Web. 17 Apr 2021.

Vancouver:

Imhof I. Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6. [Internet] [Doctoral dissertation]. University of Edinburgh; 2010. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1842/6207.

Council of Science Editors:

Imhof I. Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6. [Doctoral Dissertation]. University of Edinburgh; 2010. Available from: http://hdl.handle.net/1842/6207


The Ohio State University

27. Meister, Gabriel T. Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus.

Degree: PhD, Pathology, 2005, The Ohio State University

 Leflunomide is an experimental immunosuppressive agent that has shown efficacy as an antiviral agent against human cytomegalovirus (HCMV) and polyomavirus strain BK (BKV). An antiviral… (more)

Subjects/Keywords: HCMV; cytomegalovirus; polyomavirus; antivirals; viral replication

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Meister, G. T. (2005). Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus. (Doctoral Dissertation). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1111428519

Chicago Manual of Style (16th Edition):

Meister, Gabriel T. “Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus.” 2005. Doctoral Dissertation, The Ohio State University. Accessed April 17, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=osu1111428519.

MLA Handbook (7th Edition):

Meister, Gabriel T. “Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus.” 2005. Web. 17 Apr 2021.

Vancouver:

Meister GT. Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus. [Internet] [Doctoral dissertation]. The Ohio State University; 2005. [cited 2021 Apr 17]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1111428519.

Council of Science Editors:

Meister GT. Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus. [Doctoral Dissertation]. The Ohio State University; 2005. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1111428519

28. Shimizu, Jacqueline Farinha [UNESP]. Atividade antiviral de compostos naturais no ciclo replicativo do HCV.

Degree: 2016, Universidade Estadual Paulista (UNESP)

Submitted by Jacqueline Farinha Shimizu null ([email protected]) on 2016-03-16T13:12:47Z No. of bitstreams: 1 Dissertação de mestrado Jacqueline Farinha Shimizu.pdf: 6141560 bytes, checksum: 69c0e6370dcc6ad5c16445f92ae60e67 (MD5)

Approved… (more)

Subjects/Keywords: Vírus da Hepatite C; Antivirais; Compostos naturais; Hepatitis C Virus; Antivirals; Natural compounds

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shimizu, J. F. [. (2016). Atividade antiviral de compostos naturais no ciclo replicativo do HCV. (Masters Thesis). Universidade Estadual Paulista (UNESP). Retrieved from http://hdl.handle.net/11449/136314

Chicago Manual of Style (16th Edition):

Shimizu, Jacqueline Farinha [UNESP]. “Atividade antiviral de compostos naturais no ciclo replicativo do HCV.” 2016. Masters Thesis, Universidade Estadual Paulista (UNESP). Accessed April 17, 2021. http://hdl.handle.net/11449/136314.

MLA Handbook (7th Edition):

Shimizu, Jacqueline Farinha [UNESP]. “Atividade antiviral de compostos naturais no ciclo replicativo do HCV.” 2016. Web. 17 Apr 2021.

Vancouver:

Shimizu JF[. Atividade antiviral de compostos naturais no ciclo replicativo do HCV. [Internet] [Masters thesis]. Universidade Estadual Paulista (UNESP); 2016. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/11449/136314.

Council of Science Editors:

Shimizu JF[. Atividade antiviral de compostos naturais no ciclo replicativo do HCV. [Masters Thesis]. Universidade Estadual Paulista (UNESP); 2016. Available from: http://hdl.handle.net/11449/136314


Universidade Nova

29. Brandão, Ruben Alexandre Ribeiro. Characterization of NS5A and NS5B resistance-associated substitutions from genotype 1 HCV infected patients in a Portuguese cohort.

Degree: 2018, Universidade Nova

 Hepatitis C virus (HCV) is considered to be the leading cause of hepatocellular carcinoma (HCC). During the last years, several highly efficacy regimens of direct-acting… (more)

Subjects/Keywords: Hepatitis C virus; Direct-acting antivirals; Resistance-associated substitutions; NS5A; NS5B; Domínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e Tecnologias

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Brandão, R. A. R. (2018). Characterization of NS5A and NS5B resistance-associated substitutions from genotype 1 HCV infected patients in a Portuguese cohort. (Thesis). Universidade Nova. Retrieved from https://www.rcaap.pt/detail.jsp?id=oai:run.unl.pt:10362/37051

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Brandão, Ruben Alexandre Ribeiro. “Characterization of NS5A and NS5B resistance-associated substitutions from genotype 1 HCV infected patients in a Portuguese cohort.” 2018. Thesis, Universidade Nova. Accessed April 17, 2021. https://www.rcaap.pt/detail.jsp?id=oai:run.unl.pt:10362/37051.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Brandão, Ruben Alexandre Ribeiro. “Characterization of NS5A and NS5B resistance-associated substitutions from genotype 1 HCV infected patients in a Portuguese cohort.” 2018. Web. 17 Apr 2021.

Vancouver:

Brandão RAR. Characterization of NS5A and NS5B resistance-associated substitutions from genotype 1 HCV infected patients in a Portuguese cohort. [Internet] [Thesis]. Universidade Nova; 2018. [cited 2021 Apr 17]. Available from: https://www.rcaap.pt/detail.jsp?id=oai:run.unl.pt:10362/37051.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Brandão RAR. Characterization of NS5A and NS5B resistance-associated substitutions from genotype 1 HCV infected patients in a Portuguese cohort. [Thesis]. Universidade Nova; 2018. Available from: https://www.rcaap.pt/detail.jsp?id=oai:run.unl.pt:10362/37051

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

30. Billioud, Gaëtan. Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants.

Degree: Docteur es, Biologie, 2011, Université Claude Bernard – Lyon I

Les traitements actuels contre le virus de l’hépatite B (VHB) combinent un ou plusieurs analogues de nucléos(t)ides qui inhibent directement la réplication virale en bloquant… (more)

Subjects/Keywords: VHB; Performances; Antiviraux; Analogues de nucléosides; Résistance; Sélection; Quasi-espèce; HBV; Fitness; Antivirals; Nucleoside analogs; Resistance; Selection; Quasi-species; 616.91

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Billioud, G. (2011). Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants. (Doctoral Dissertation). Université Claude Bernard – Lyon I. Retrieved from http://www.theses.fr/2011LYO10077

Chicago Manual of Style (16th Edition):

Billioud, Gaëtan. “Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants.” 2011. Doctoral Dissertation, Université Claude Bernard – Lyon I. Accessed April 17, 2021. http://www.theses.fr/2011LYO10077.

MLA Handbook (7th Edition):

Billioud, Gaëtan. “Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants.” 2011. Web. 17 Apr 2021.

Vancouver:

Billioud G. Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants. [Internet] [Doctoral dissertation]. Université Claude Bernard – Lyon I; 2011. [cited 2021 Apr 17]. Available from: http://www.theses.fr/2011LYO10077.

Council of Science Editors:

Billioud G. Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants. [Doctoral Dissertation]. Université Claude Bernard – Lyon I; 2011. Available from: http://www.theses.fr/2011LYO10077

[1] [2] [3] [4]

.